Oncology Infusion PA: From 6-Day Wait to Under 36-Hour Turnaround
This outsourced prior authorization case study covers a 14-provider community oncology infusion center that was losing chair time and writing off J-code drugs after retroactive denials. After engaging Staffingly’s dedicated remote PA team, a HIPAA-compliant healthcare BPO with named specialists, not a shared offshore pool, average turnaround dropped to under 36 hours, first-pass approvals climbed to 87%, and the practice protected an estimated $1.4M in quarterly J-code revenue.
See Your Oncology PA Backlog Cleared in 2 Weeks
Free assessment, no obligation, no high-pressure pitch.
What happens when oncology prior authorization is handled in-house without dedicated outsourcing?
Community oncology lives or dies on infusion chair utilization. Every J-code drug administered without an approved prior authorization is a write-off waiting to happen, and every delayed chemotherapy start is a clinical risk the medical director must defend. This 14-provider infusion center was facing both problems simultaneously, and the root cause was an overwhelmed in-house PA workflow with no systematic structure.
Before outsourcing prior authorization to Staffingly, two full-time staff were processing nothing but PA requests. The medical director was still personally writing letters of medical necessity for biologics and targeted therapies on weekends. Three failure modes kept repeating.
Inconsistent NCCN citations
The same regimen would be approved by one reviewer and denied by another because guideline citations were not standardized across requests.
Incomplete clinical packets
No clean intake process for capturing pathology, staging, biomarker results, and prior therapy history at the point of order. Packets were assembled twice.
Reactive P2P scheduling
Peer-to-peer requests piled up because no single person owned the calendar. Recovery was weeks, not days.
Financial exposure: KFF’s 2024 Medicare Advantage analysis found plans denied 7.7% of 53 million PA requests, with denial rates reaching 12.8% at some major insurers. For oncology, even a 5% retroactive denial rate on J-code drugs can wipe out the margin on an entire infusion suite. CMS-0057-F (effective 2026) mandates 7-day standard and 72-hour expedited decisions, the practice’s manual workflow could not meet that standard.
How does outsourced prior authorization work for an oncology infusion center?
Staffingly stood up a dedicated oncology PA pod within 10 business days. The pod operates as a tiered outsourced team: overseas-licensed MDs and pharmacists own clinical packet assembly and NCCN guideline citations; trained remote virtual medical assistants run payer portals and fax workflows; a US-facing coordinator handles peer-to-peer scheduling and real-time escalations with the practice’s oncologists.
Intake redesign
Every infusion order triggers a single PA worksheet capturing ICD-10, J-code, regimen line, biomarker results, prior therapy failures, and NCCN compendia citations, locked before it leaves the practice.
Payer-specific playbooks
Living documentation for the top 12 commercial and Medicare Advantage payers: portal quirks, fax vs portal preference, required attachments, and known denial patterns by J-code. Updated same day when payer policy changes.
P2P desk ownership
One coordinator owns a single calendar across all 14 providers, books peer-to-peer slots within 48 hours of any denial, and pre-loads each physician with a denial brief including NCCN page citations and counter-arguments.
Compliance posture: HIPAA · SOC 2 Type II · ISO 27001 · HITRUST · BAA signed at onboarding. PHI never leaves the practice’s EHR environment. The dedicated, remote team works inside the practice’s own system under role-based access, not a shared offshore pool.
Six metrics that moved inside 90 days
Industry benchmarks pulled from AMA 2024 PA Survey, KFF 2024 Medicare Advantage data, CAQH 2024 Index, and CMS-0057-F regulatory timelines. Staffingly results are composite outcomes across 5 oncology engagements.
| Metric | Industry Benchmark | Staffingly Result | Improvement |
|---|---|---|---|
| Average PA turnaround | 5 to 10 business days (AMA 2024) | Under 36 hours | 78% faster |
| First-pass approval rate | 55 to 70% typical | 87% | +17 pts |
| Denial overturn on appeal | 50 to 60% industry, 80.7% MA when appealed (KFF) | 64% | Within range, repeatable |
| PAs processed per VA per day | 8 to 12 in-house typical | 20 to 24 | +100% |
| Provider hours saved per week | 0 baseline | 10 to 12 hours | Reclaimed for clinic |
| Cost per PA vs in-house | $10.92 manual (CAQH 2024) | 55 to 60% lower | Savings reinvested in chair time |
How does outsourcing oncology prior authorization change the numbers?
Conservative model: 39 PAs/provider/week (AMA 2024) · $10.92 manual cost per PA (CAQH 2024) · Staffingly team rate $349/week. Run it with your numbers →
protected from retroactive denials
vs in-house staffing
reclaimed per week
approval rate (up from ~52%)
What separates us from typical vendors
We don't name competitors. Ask your current vendor for proof of all four certifications. We will wait.
| Capability | Typical Vendor | Staffingly |
|---|---|---|
| Certification Stack | HIPAA training only | HIPAA + SOC 2 Type II + ISO 27001 + HITRUST |
| Clinical Credentials | General virtual assistants | Overseas-licensed MDs, RNs, PharmDs, billers |
| Risk-Free Pilot | No trial period | 2-Week Risk-Free Pilot, full refund if not satisfied |
| Pricing Transparency | Quote-only, hidden setup fees | $399/wk single, $349/wk team, $299/wk dept |
| Oncology Clinical Depth | Generalist agents reading scripts | NCCN guideline mapping, J-code expertise, biomarker context |
Where AI carries the load, and where licensed humans still own the call
The oncology PA pod uses automation aggressively, but every clinical decision still routes to a licensed human. Here is the split:
What AI handles. Payer portal navigation and form pre-fill, J-code and CPT lookup, NCCN compendia citation matching, denial reason pattern recognition across the last 12 months of decisions, peer-to-peer slot scoring against payer reviewer availability, and clinical packet assembly from the EHR using structured templates. The system also flags which payers are sliding outside the CMS-0057-F 7-day standard so the coordinator can escalate before the deadline lapses.
What licensed humans still own. The clinical narrative in any letter of medical necessity. The judgment call on whether an off-label or off-pathway request is worth pursuing or should be re-routed to an on-pathway alternative. Peer-to-peer execution. Appeals strategy on complex denials, especially second-line biologics. Communication with the practice's oncologists when a payer asks for additional staging or biomarker data.
The AMA 2024 survey reported that 61% of physicians are concerned AI will increase denial rates if payers deploy it without clinical oversight. Staffingly's model is the opposite. AI compresses the clerical work that consumes 13 hours per physician per week. The clinical decision stays with credentialed reviewers who are accountable to the practice's medical director and operate under HIPAA, SOC 2 Type II, ISO 27001, and HITRUST controls.
Questions practice operators ask before signing
Staffingly charges a flat per-specialist weekly fee, $399/week for one dedicated remote PA specialist, $349/week for five or more (volume), and $299/week for ten or more (enterprise). There is no percentage of collections, no percentage of revenue recovered, and no per-authorization fee. The outsourcing model is designed for practices that want predictable costs and a dedicated, HIPAA-compliant team rather than a shared offshore pool or a software subscription that still requires in-house staff to run it.
Dan Nandan is the President and CEO of Staffingly, Inc. With 25+ years in IT consulting and healthcare BPO operations, he was one of the earliest U.S. operators to set up an RPO/BPO delivery network in India over 20 years ago. Today his work centers on AI-driven healthcare workflows and helping practices across North America cut administrative costs without compromising care.
Bincy Shiiju Kuriakose is a Clinical Content Reviewer at Staffingly and a U.S. Licensed Registered Nurse (MSN, RN). NCLEX-RN certified with expertise in hospital nursing, telehealth, and nursing education. PhD scholar in Nursing at Peoples' College of Nursing, Bhopal. Reviews every service page for medical accuracy, compliance, and evidence-based best practices.
Outsource the workflow behind this result
Stop losing chair time to prior authorization
Run a 2-week risk-free pilot. We work your real backlog, hit the CMS-0057-F clock from day one, and you keep every approval we secure even if you walk away.
